Skip to main navigation Skip to search Skip to main content

Effectiveness of daptomycin against infective endocarditis caused by highly penicillin-resistant viridans group streptococci

Research output: Contribution to journal › Article › peer-review

Abstract

Penicillin-resistant viridans group streptococci (VGS) infections are an emerging issue in infectious diseases. Here, we present a case of mitral valve infective endocarditis caused by highly penicillin-resistant VGS (minimum inhibitory concentration >4 μg/mL), which was successfully treated with daptomycin. Although the clinical efficacy of daptomycin has not been established, it can be an alternative for the treatment of highly resistant VGS endocarditis.

Original languageEnglish
Article numbere01113
JournalIDCases
Volume24
DOIs
Publication statusPublished - 01-2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Effectiveness of daptomycin against infective endocarditis caused by highly penicillin-resistant viridans group streptococci'. Together they form a unique fingerprint.

Cite this